BioTech, the new Big Pharma? BD
John LaMattina, a chemist who retired as head of Pfizer R&D last year, has been named to the board of directors of Human Genome Sciences, a biotech company still looking for its first product.
LaMattina joins a cast of former Big Pharma honchos on the HGS board, including Chairman Jerry Karabelas, formerly of Novartis; Jürgen Drews, ex-Roche; and Maxine Gowen, ex-GlaxoSmithKline.
Health Blog : Ex-Pfizer R&D Chief LaMattina Joins Human Genome Board
0 comments :
Post a Comment